Home      Site Map      Contact      Links      Medical News      


allergy care centers virginia


Generic medication at fraction of the cost. Asthma.
Over 500 generics available for immediate delivery. Orders can be tracked online. 10% rebate for reorders. Full refund option.
Generics at fraction of the cost. Asthma.
Over 500 generics in stock. Licensed online pharmacy. No prescription needed. 10% rebate on reorders. Orders can be tracked online.
Discount accolate Prices
Discount prices - Buy Discount Prescription Drugs and Save Up To 80%.
Generic medication Low prices
Generic medication from Licensed online pharmacy FREE doctors consultation SAVE up to 70%
ACCOLATE: Find More Information here
Get best results for accolate. Get 10 most relevant accolate results.
Accolate
LowPriceShopper for all your shopping needs!
Buy Tramadol Online!
Tramadol. Offer review from dozens of shops. Daily list of the hottest offers on tramadol.
Accolate
LowPriceShopper for all your shopping needs!
Looking For Cheap Viagra??
Compare Prices For Viagra In Top 10 Online DrugStores. Daily Updated!
My EverydayHealth
Create a Homepage. Connect with others like you. Customize a meal plan - It's all free!

allergy care centers virginia
DESCRIPTION
Zafirlukast is a synthetic, selective peptide leukotriene receptor antagonist(LTRA), with the chemical name 4-(5-cyclopentyloxy-carbonylamino-1-methyl-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide allergy care centers virginia. The molecular weight of zafirlukast is 575.7 and the structural formula is:



The empirical formula is: C 31 H 33 N 3 O 6 S

Zafirlukast, a fine white to pale yellow amorphous powder, is practically insolublein water allergy care centers virginia. It is slightly soluble in methanol and freely soluble in tetrahydrofuran,dimethylsulfoxide, and acetone allergy care centers virginia.

ACCOLATE is supplied as 10 and 20 mg tablets for oral administration allergy care centers virginia.

Inactive Ingredients: Film-coated tablets containing croscarmellose sodium,lactose, magnesium stearate, microcrystalline cellulose, povidone, hypromellose,and titanium dioxide allergy care centers virginia.


CLINICAL PHARMACOLOGY
Mechanism of Action
Zafirlukast is a selective and competitive receptor antagonist of leukotrieneD 4 and E 4 (LTD 4 and LTE 4 ), components of slow-reacting substance of anaphylaxis(SRSA) allergy care centers virginia. Cysteinyl leukotriene production and receptor occupation have been correlatedwith the pathophysiology of asthma, including airway edema, smooth muscle constriction,and altered cellular activity associated with the inflammatory process, whichcontribute to the signs and symptoms of asthma allergy care centers virginia. Patients with asthma were foundin one study to be 25-100 times more sensitive to the bronchoconstricting activityof inhaled LTD 4 than nonasthmatic subjects allergy care centers virginia.

In vitro studies demonstrated that zafirlukast antagonized the contractileactivity of three leukotrienes (LTC 4 , LTD 4 and LTE 4 ) in conducting airwaysmooth muscle from laboratory animals and humans allergy care centers virginia. Zafirlukast prevented intradermalLTD 4 -induced increases in cutaneous vascular permeability and inhibited inhaledLTD 4 -induced influx of eosinophils into animal lungs allergy care centers virginia. Inhalational challengestudies in sensitized sheep showed that zafirlukast suppressed the airway responsesto antigen; this included both the early- and late-phase response and the nonspecifichyperresponsiveness allergy care centers virginia.

In humans, zafirlukast inhibited bronchoconstriction caused by several kindsof inhalational challenges allergy care centers virginia. Pretreatment with single oral doses of zafirlukastinhibited the bronchoconstriction caused by sulfur dioxide and cold air in patientswith asthma allergy care centers virginia. Pretreatment with single doses of zafirlukast attenuated the early-and late-phase reaction caused by inhalation of various antigens such as grass,cat dander, ragweed, and mixed antigens in patients with asthma allergy care centers virginia. Zafirlukastalso attenuated the increase in bronchial hyperresponsiveness to inhaled histaminethat followed inhaled allergen challenge allergy care centers virginia.

Clinical Pharmacokinetics and Bioavailability:
Absorption
Zafirlukast is rapidly absorbed following oral administration allergy care centers virginia. Peak plasma concentrationsare generally achieved 3 hours after oral administration allergy care centers virginia. The absolute bioavailabilityof zafirlukast is unknown allergy care centers virginia. In two separate studies, one using a high fat andthe other a high protein meal, administration of zafirlukast with food reducedthe mean bioavailability by approximately 40% allergy care centers virginia.

Distribution
Zafirlukast is more than 99% bound to plasma proteins, predominantly albumin allergy care centers virginia. The degree of binding was independent of concentration in the clinically relevantrange allergy care centers virginia. The apparent steady-state volume of distribution (V SS /F) is approximately70 L, suggesting moderate distribution into tissues allergy care centers virginia. Studies in rats using radiolabeledzafirlukast indicate minimal distribution across the blood-brain barrier allergy care centers virginia.

Metabolism
Zafirlukast is extensively metabolized allergy care centers virginia. The most common metabolic products arehydroxylated metabolites which are excreted in the feces allergy care centers virginia. The metabolites ofzafirlukast identified in plasma are at least 90 times less potent as LTD 4receptor antagonists than zafirlukast in a standard in vitro test of activity allergy care centers virginia. In vitro studies using human liver microsomes showed that the hydroxylated metabolitesof zafirlukast excreted in the feces are formed through the cytochrome P4502C9 (CYP2C9) pathway allergy care centers virginia. Additional in vitro studies utilizing human liver microsomesshow that zafirlukast inhibits the cytochrome P450 CYP3A4 and CYP2C9 isoenzymesat concentrations close to the clinically achieved total plasma concentrations(see Drug Interactions ) allergy care centers virginia.

Excretion
The apparent oral clearance (CL/f) of zafirlukast is approximately 20 L/h allergy care centers virginia. Studiesin the rat and dog suggest that biliary excretion is the primary route of excretion allergy care centers virginia. Following oral administration of radiolabeled zafirlukast to volunteers, urinaryexcretion accounts for approximately 10% of the dose and the remainder is excretedin feces allergy care centers virginia. Zafirlukast is not detected in urine allergy care centers virginia.

In the pivotal bioequivalence study, the mean terminal half-life of zafirlukastis approximately 10 hours in both normal adult subjects and patients with asthma allergy care centers virginia. In other studies, the mean plasma half-life of zafirlukast ranged from approximately8 to 16 hours in both normal subjects and patients with asthma allergy care centers virginia. The pharmacokineticsof zafirlukast are approximately linear over the range from 5 mg to 80 mg allergy care centers virginia. Steady-stateplasma concentrations of zafirlukast are proportional to the dose and predictablefrom single-dose pharmacokinetic data allergy care centers virginia. Accumulation of zafirlukast in the plasmafollowing twice-daily dosing is approximately 45% allergy care centers virginia.

The pharmacokinetic parameters of zafirlukast 20 mg administered as a singledose to 36 male volunteers are shown with the table below allergy care centers virginia.

Mean (% Coefficient of Variation) pharmacokinetic
parameters of zafirlukast following single 20 mg
oral dose administration to male volunteers (n=36) C max
ng/mL t max h AUC
ng·h/mL t 1/2
h CL/f
L/h
326 (31.0) 2 (0.5-5.0) 1137 (34) 13.3 (75.6) 19.4 (32)
1 Median and range


Special Populations
Gender: The pharmacokinetics of zafirlukast are similar in males and females allergy care centers virginia. Weight-adjusted apparent oral clearance does not differ due to gender allergy care centers virginia.

Race: No differences in the pharmacokinetics of zafirlukast due to race havebeen observed allergy care centers virginia.

Elderly: The apparent oral clearance of zafirlukast decreases with age allergy care centers virginia. Inpatients above 65 years of age, there is an approximately 2-3 fold greater Cmax and AUC compared to young adult patients allergy care centers virginia.

Children: Following administration of a single 20 mg dose of zafirlukast to20 boys and girls between 7 and 11 years of age, and in a second study, to 29boys and girls between 5 and 6 years of age, the following pharmacokinetic parameterswere obtained:

Parameter Children age
5-6 years
Mean (% Coefficient
of Variation) Children age
7-11 years
Mean (% Coefficient
of Variation)
C max (ng/mL) 756 (39%) 601 (45%)
AUC (ng·h/mL) 2458 (34%) 2027 (38%)
t max (h) 2.1 (61%) 2.5 (55%)
CL/f (L/h) 9.2 (37%) 11.4 (42%)


Weight unadjusted apparent clearance was 11.4 L/h (42%) in the 7-11 year oldchildren and 9.2 L/h (37%) in the 5-6 year old children, which resulted in greatersystemic drug exposures than that obtained in adults for an identical dose allergy care centers virginia. To maintain similar exposure levels in children compared to adults, a dose of10 mg twice daily is recommended in children 5-11 years of age (see DOSAGE ANDADMINISTRATION ) allergy care centers virginia.

Zafirlukast disposition was unchanged after multiple dosing (20 mg twice daily)in children and the degree of accumulation in plasma was similar to that observedin adults allergy care centers virginia.

Hepatic Insufficiency: In a study of patients with hepatic impairment (biopsy-provencirrhosis), there was a reduced clearance of zafirlukast resulting in a 50-60%greater C max and AUC compared to normal subjects allergy care centers virginia.

Renal Insufficiency: Based on a cross-study comparison, there are no apparentdifferences in the pharmacokinetics of zafirlukast between renally-impairedpatients and normal subjects allergy care centers virginia.

Drug-Drug Interactions
The following drug interaction studies have been conducted with zafirlukast(see PRECAUTIONS , Drug Interactions ) allergy care centers virginia.


Coadministration of multiple doses of zafirlukast (160 mg/day) to steady-statewith a single 25 mg dose of warfarin (a substrate of CYP2C9) resulted in a significantincrease in the mean AUC (+63%) and half-life (+36%) of S-warfarin allergy care centers virginia. The meanprothrombin time increased by approximately 35% allergy care centers virginia. The pharmacokinetics of zafirlukastwere unaffected by coadministration with warfarin allergy care centers virginia.
Coadministration of zafirlukast (80 mg/day) at steady-state with a single doseof a liquid theophylline preparation (6 mg/kg) in 13 asthmatic patients, 18to 44 years of age, resulted in decreased mean plasma concentrations of zafirlukastby approximately 30%, but no effect on plasma theophylline concentrations wasobserved allergy care centers virginia.
Coadministration of zafirlukast (20 mg/day) or placebo at steady-state witha single dose of sustained release theophylline preparation (16 mg/kg) in 16healthy boys and girls (6 through 11 years of age) resulted in no significantdifferences in the pharmacokinetic parameters of theophylline allergy care centers virginia.
Coadministration of zafirlukast dosed at 40 mg twice daily in a single-blind,parallel-group, 3-week study in 39 healthy female subjects taking oral contraceptives,resulted in no significant effect on ethinyl estradiol plasma concentrationsor contraceptive efficacy allergy care centers virginia.
Coadministration of zafirlukast (40 mg/day) with aspirin (650 mg four timesdaily) resulted in mean increased plasma concentrations of zafirlukast by approximately45% allergy care centers virginia.
Coadministration of a single dose of zafirlukast (40 mg) with erythromycin (500mg three times daily for 5 days) to steady-state in 11 asthmatic patients resultedin decreased mean plasma concentrations of zafirlukast by approximately 40%due to a decrease in zafirlukast bioavailability allergy care centers virginia.


outdoor allergy   allergy bedding   allergy tests   dogs for allergy sufferers   environmental allergies   toddler allergies   allergy research   allergy induced asthma   asthma fact or fiction   gluten allergy   accolate asthma treatment   the cause of asthma   accolate   sugar allergy   dog allergies   environmental allergies   asthma inhaler holder   peanut allergies   sun allergy   whey allergy   excersice induced asthma   national allergy supply   allergy asthma and complimentary medicine treatments   countries least affected by asthma   504 plan for children with food allergies   fall allergies lung congestion   seasonal allergies   shellfish allergy   asthma medication side effects   allergy and deodorant   lung asthma   onion allergies   how asthma is treated   asthma attack   sinus allergies   best dog for allergies   cat allergies   asthma causes   mold mildew allergies   allergy test   asthma prevention   allergy medication   asthma australia   yoga for allergies   cough variant asthma   children allergies   honey allergy   asthma diet   home remedies asthma attack, coke   asthma drugs   asthma allergy   asthma medication side effects   phosphate allergies   allergies and pregnancy   accolate peak flow age   signs and symptoms of asthma   allergies and weight gain   herbal allergy relief   cat asthma   allergy information   accolate asthma treatment   bombyx mori allergy   penicillin allergy   allergy alert   asthma symptoms   what are the symptoms of dog asthma   information on asthma   cashew allergy  

abilify  abraxane  accolate  accupril  accutane  acetaminophen  aciphex  aclovate  actifed  activase  actiza  actonel  actos  aczone  adacel  adalat  adderall  adipex  advair  advate  agilect  albalon  albuterol  aldomet  alesse  aleve  alimta  allegra  aloxi  alphagan  alprazolam  altace  altocor  alvesco  amaryl  ambien  amiodarone  amitriptyline  amoxicillin  androgel  angeliq  anidulafungin  antabuse  antegren  anusol  apidra  apokyn  arthrotec  asacol  aspirin  atenolol  ativan  augmentin  avandia  avapro  avastin  avelox  axid 

aallergy care centers virginia alllergy care centers virginia alllergy care centers virginia alleergy care centers virginia allerrgy care centers virginia allerggy care centers virginia allergyy care centers virginia allergy care centers virginia allergy ccare centers virginia allergy caare centers virginia allergy carre centers virginia allergy caree centers virginia allergy care centers virginia allergy care ccenters virginia allergy care ceenters virginia allergy care cennters virginia allergy care centters virginia allergy care centeers virginia allergy care centerrs virginia allergy care centerss virginia allergy care centers virginia allergy care centers vvirginia allergy care centers viirginia allergy care centers virrginia allergy care centers virgginia allergy care centers virgiinia allergy care centers virginnia allergy care centers virginiia allergy care centers virginiaa llergy care centers virginia alergy care centers virginia alergy care centers virginia allrgy care centers virginia allegy care centers virginia allery care centers virginia allerg care centers virginia allergycare centers virginia allergy are centers virginia allergy cre centers virginia allergy cae centers virginia allergy car centers virginia allergy carecenters virginia allergy care enters virginia allergy care cnters virginia allergy care ceters virginia allergy care ceners virginia allergy care centrs virginia allergy care centes virginia allergy care center virginia allergy care centersvirginia allergy care centers irginia allergy care centers vrginia allergy care centers viginia allergy care centers virinia allergy care centers virgnia allergy care centers virgiia allergy care centers virgina allergy care centers virgini a llergy care centers virginia al lergy care centers virginia all ergy care centers virginia alle rgy care centers virginia aller gy care centers virginia allerg y care centers virginia allergy care centers virginia allergy care centers virginia allergy c are centers virginia allergy ca re centers virginia allergy car e centers virginia allergy care centers virginia allergy care centers virginia allergy care c enters virginia allergy care ce nters virginia allergy care cen ters virginia allergy care cent ers virginia allergy care cente rs virginia allergy care center s virginia allergy care centers virginia allergy care centers virginia allergy care centers v irginia allergy care centers vi rginia allergy care centers vir ginia allergy care centers virg inia allergy care centers virgi nia allergy care centers virgin ia allergy care centers virgini a allergy care centers virginia lalergy care centers virginia allergy care centers virginia alelrgy care centers virginia allregy care centers virginia allegry care centers virginia alleryg care centers virginia allerg ycare centers virginia allergyc are centers virginia allergy acre centers virginia allergy crae centers virginia allergy caer centers virginia allergy car ecenters virginia allergy carec enters virginia allergy care ecnters virginia allergy care cneters virginia allergy care cetners virginia allergy care cenetrs virginia allergy care centres virginia allergy care centesr virginia allergy care center svirginia allergy care centersv irginia allergy care centers ivrginia allergy care centers vriginia allergy care centers vigrinia allergy care centers virignia allergy care centers virgniia allergy care centers virgiina allergy care centers virginai aallergy care centers virginia theallergy care centers virginia allergy care centers virginia

a  b  c  d  e  f  g  h  i  k  l  m  n  o  p  r  s  t  u  v  w  x  z 

Copyright 2005 D-S LTD.
All Rights Reserved.